HomeHealthcareDiagnosticsGlobal Consumer DNA (Genetic) Testing Market

Global Consumer DNA (Genetic) Testing Market - Strategic Insights and Forecasts (2025-2030)

Evaluation of consumer DNA testing market growth supported by personalized medicine and wellness trends.

📥 Download Free Sample💬 Speak to Analyst
$3,950
Single User License
Access Full Insights
Market Size
USD 3.161 billion
by 2030
CAGR
11.76%
2025-2030
Base Year
2024
Forecast Period
2025-2030
Projection
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

🎯

Global Consumer DNA (Genetic) Highlights

Automotive production surge drives TPMS sensor demand rapidly.
Record US oil output boosts pipeline monitoring requirements.
IoT expansion accelerates smart device sensor integration.
Industrial automation enhances manufacturing precision significantly.

The Global Consumer DNA (Genetic) Testing Market will soar from USD 1.813 billion in 2025 to USD 3.161 billion in 2030, with an 11.76% compound annual growth rate (CAGR).

Genetic or DNA testing usually refers to medical tests that examine and evaluates the changes in chromosomes, genes, or several types of proteins to help a person’s chance of developing one or rule out a suspected genetic condition. The market is expected to surge in the coming years, due to the rise in the demand for direct-to-consumer genetic testing, identity seeking, and other related factors. Increasing and raising awareness about novel developments and advancements in the DNA testing market is expected to play a major role in the overall market growth. Major companies such as Ancestry and 23andMe have been investing a significant sum of capital to develop advanced and innovative superior and excellent direct-to-consumer genetic testing and other related solutions. Moreover, the growth in genetic ancestry testing is also expected to play a major and imperative role in the market growth, during the forecast period. These trends are expected to have a positive impact on the market, in the coming years.

Consumer DNA (Genetic) Testing Market Driver:

  • A rise in Genetic Ancestry Testing

Genetic ancestry testing is defined as a way for an individual to learn more about his family’s genealogy or want to go beyond data collection from historical documentation. There has been a surge in the demand for ancestry testing, with the use of cheek swabs or saliva DNA test kits, especially in the regions like Europe and North America. According to the data given by the MIT Institute and Technology, more than 26 million customers had added their respective DNA to four major health databases and commercial ancestry. Moreover, according to Ancestry and 23andMe, two of the major players in the market, the companies have now a collection of some of the world’s biggest collections of human DNAs. With the affordable pricing of around US$59, these DNA tests offer a plethora of entertainment, a major chance of discovering family and ancestry secrets, such as estranged siblings. Ancestry also claimed that they had registered a record Thanksgiving sale in the month of November 2018 and sold a total number of test kits at around 14 million. Moreover, other companies are also making significant developments in the market. For instance, Gene By Gene[1], one of the major firms in the market, had stated that its family tree DNA ancestry database contains approx. 2 million people. Another company, known as MyHeritage, a major Israeli firm, had stated that their database has around 2.5 million profiles. Moreover, the growth in direct-to-consumer DNA testing is also expected to have a major impact on the market. According to several official figures, there had been an expectation of sales of around 100 million kits by the year 2021. A plethora of companies has been providing DNA testing services to their customers, in the past few years. For instance, in December 2020, MyHeritage, a major global service for identifying your past and future company, announced the launch of genetic groups.

The genetic groups would be able to identify and find ancestral origins with high-resolution data of around 2100 geographic regions. This development is expected to enhance the company’s market share, in the coming years. Other players are also making significant developments in the market. In January 2021, myDNA, a major Australian genomics company, announced a merger with FamilyTreeDNA, a US-based consumer DNA test company, and with Gene By Gene, the parent company of FamilyTreeDNA. The innovative merger of these companies is expected to be a major development for the market, as the companies would aim to focus on the enhancement of a scientific foundation for personalized and actionable insights. Asia Pacific region is expected to have a major share in the market, due to the rise in the number of start-ups and increasing excitement about ancestral DNA testing.

Consumer DNA (Genetic) Testing Market Scope:

Report Metric Details
Total Market Size in 2025 USD 1.813 billion
Total Market Size in 2030 USD 3.161 billion
Forecast Unit Billion
Growth Rate 11.76%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Segmentation Gender, Age Group, Application, Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies
  • Quest Diagnostics Inc.
  • Mapmygenome 
  • Labcorp
  • Gene by Gene, Ltd
  • Myriad Genetics
  • Color Health Inc.
  • 23andMe Inc.
  • Ancestry
  • Veritas Genetics
  • Nebula Genomics

REPORT DETAILS

Report ID:KSI061611330
Published:Mar 2026
Pages:150
Format:PDF, Excel, PPT, Dashboard
📥 Download Sample📞 Speak to Analyst📧 Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The Global Consumer DNA (Genetic) Testing Market is projected to experience substantial growth, increasing from USD 1.813 billion in 2025 to USD 3.161 billion by 2030. This expansion reflects an impressive compound annual growth rate (CAGR) of 11.76% over the forecast period, as detailed in the report.

The market's surge is primarily driven by the increasing demand for direct-to-consumer genetic testing and identity seeking. A significant catalyst is the rise in genetic ancestry testing, which offers individuals a way to explore their family genealogy beyond historical documentation, coupled with growing awareness of advancements in the DNA testing market.

Key companies dominating the Consumer DNA (Genetic) Testing Market include industry giants like Ancestry and 23andMe, both of whom have invested significantly in developing advanced direct-to-consumer solutions. Other notable firms contributing to the market include Gene By Gene (known for its Family Tree DNA database) and MyHeritage, an Israeli firm.

The report highlights a particular surge in demand for ancestry testing, utilizing cheek swabs or saliva DNA test kits, especially within regions like Europe and North America. This indicates these areas are key hotspots for the adoption and growth of direct-to-consumer genetic genealogy services.

Major trends positively impacting the market include the continued rise in direct-to-consumer genetic testing and identity seeking, driven by advancements and increasing awareness. The growth in genetic ancestry testing, coupled with the affordability of kits (around US$59), is expected to be a major and imperative factor in market growth throughout the forecast period.

Genetic ancestry testing is a highly significant driver, enabling individuals to explore their family genealogy. Companies like Ancestry and 23andMe have accumulated vast collections of human DNA, with Ancestry alone selling 14 million test kits in November 2018, demonstrating widespread consumer engagement and its substantial contribution to market expansion. Gene By Gene and MyHeritage also contribute with millions of profiles in their databases.

Related Reports

Healthcare

Epigenetics Diagnostics Market - Strategic Insights and Forecasts (2026-2031)

Feb 2026
Healthcare

Esoteric Testing Market Size, Share, Opportunities, And Trends By Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other Testing), By Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA Sequencing, Flow Cytometry, Other Technologies), By End-User (Independent and Reference Laboratories, Hospital Laboratories), And By Geography - Forecasts From 2024 To 2029

Feb 2024
Healthcare

Preimplantation Genetic Testing Market - Strategic Insights and Forecasts (2025-2030)

Jun 2024
Healthcare

DNA Synthesizer Market - Strategic Insights and Forecasts (2026-2031)

Jan 2026
View All Reports